Pacer Advisors, Inc. Replimune Group, Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$6.87 - $9.31 $20,500 - $27,781	2,984 New	2,984 $24,000
Q2 2021 Jul 21, 2021	SELL	$28.5 - $39.37 $65,208 - $90,078	-2,288 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$30.22 - $45.57 $3,505 - $5,286	-116 Reduced 4.83%	2,288 $70,000
Q4 2020 Jan 20, 2021	BUY	$23.5 - $52.65 $56,494 - $126,570	2,404 New	2,404 $92,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.